Literature DB >> 23139711

Dynamic tracing of immune cells in an orthotopic gastric carcinoma mouse model using near-infrared fluorescence live imaging.

Xiaohui DU1, Xiangyu Wang, Ning Ning, Shaoyou Xia, Juchao Liu, Wentao Liang, Huiwei Sun, Yingxin Xu.   

Abstract

Adoptive cellular immunotherapy (ACI) has been demonstrated to be a promising cancer therapeutic, however, the distribution of immune cells injected into a tumor-bearing body is unclear. In this study, we investigated the tumor-targeting capacity of cytokine-induced killer (CIK) cells and cytotoxic T lymphocytes (CTLs) in a human gastric carcinoma orthotopic mouse model using a near-infrared fluorescence imaging system. CIK cells and tumor-specific CTLs were prepared with the near-infrared fluorescent dye DiR. As expected, no significant change in the proliferation rate or antitumor activity of CIK cells and CTLs was noted after labeling with DiR. Furthermore, a gastric carcinoma orthotopic model was established using a fibrinogen-thrombin method in nude mice followed by intraperitoneal infusion of the labeled immune cells into nude mice with established gastric carcinoma. Dynamic tracing of the immune cells was performed using a fluorescence-based live imaging system. Concentrated fluorescence signals were observed for a minimum of two weeks at the tumor site in mice infused with either CIK cells or CTLs with a peak signal at 48 h. Notably, CTLs were more persistent at the tumor site and exhibited a more intense antitumor activity than CIK cells following infusion. These results provided visual evidence of the tumor-targeting capacity of immune cells in live animals.

Entities:  

Year:  2012        PMID: 23139711      PMCID: PMC3460300          DOI: 10.3892/etm.2012.579

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  25 in total

1.  Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.

Authors:  C Yee; J A Thompson; D Byrd; S R Riddell; P Roche; E Celis; P D Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

2.  Applicability of the dyes CFSE, CM-DiI and PKH26 for tracking of human preadipocytes to evaluate adipose tissue engineering.

Authors:  Karsten Hemmrich; Melanie Meersch; Dennis von Heimburg; Norbert Pallua
Journal:  Cells Tissues Organs       Date:  2006       Impact factor: 2.481

3.  A case report of immunotherapy on a patient with advanced gastric cancer by adoptive transfer of OK-432-reactive HLA-matched allogeneic lymphocytes.

Authors:  H Yamagishi; Y Ueda; T Oka
Journal:  Cancer Immunol Immunother       Date:  1998-04       Impact factor: 6.968

4.  Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts.

Authors:  Y C Linn; L C Lau; Kam M Hui
Journal:  Br J Haematol       Date:  2002-01       Impact factor: 6.998

5.  Adoptive immunotherapy using autologous lymphocytes sensitized with HLA class I-matched allogeneic tumor cells.

Authors:  Yoshiyuki Yamaguchi; Akiko Ohshita; Katsuji Hironaka; Riki Okita; Makoto Okawaki; Kazuo Matsuura; Ichiro Nagamine; Takuhiro Ikeda; Masahiro Ohara; Jun Hihara
Journal:  Oncol Rep       Date:  2006-07       Impact factor: 3.906

6.  Effective osteosarcoma cytolysis using cytokine-induced killer cells pre-inoculated with tumor RNA-pulsed dendritic cells.

Authors:  Adisak Wongkajornsilp; Sakdipat Sangsuriyong; Suradej Hongeng; Saranatra Waikakul; Apichat Asavamongkolkul; Sukit Huabprasert
Journal:  J Orthop Res       Date:  2005-11       Impact factor: 3.494

7.  Cancer immunotherapy: moving beyond current vaccines.

Authors:  Steven A Rosenberg; James C Yang; Nicholas P Restifo
Journal:  Nat Med       Date:  2004-09       Impact factor: 53.440

8.  Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model.

Authors:  Hwan Mook Kim; Jong Soon Kang; Jaeseung Lim; Jee Youn Kim; Yeon Jin Kim; Soo Jae Lee; Sukgil Song; Jin Tae Hong; Youngsoo Kim; Sang-Bae Han
Journal:  Arch Pharm Res       Date:  2009-05-27       Impact factor: 4.946

9.  Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.

Authors:  Marcus O Butler; Jeng-Shin Lee; Sascha Ansén; Donna Neuberg; F Stephen Hodi; Andrew P Murray; Linda Drury; Alla Berezovskaya; Richard C Mulligan; Lee M Nadler; Naoto Hirano
Journal:  Clin Cancer Res       Date:  2007-03-15       Impact factor: 12.531

10.  Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen.

Authors:  Chengyi J Shu; Caius G Radu; Stephanie M Shelly; Dan D Vo; Robert Prins; Antoni Ribas; Michael E Phelps; Owen N Witte
Journal:  Int Immunol       Date:  2008-12-23       Impact factor: 4.823

View more
  9 in total

1.  Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity.

Authors:  Yang Yan; Songyan Li; Tingting Jia; Xiaohui Du; Yingxin Xu; Yunshan Zhao; Li Li; Kai Liang; Wentao Liang; Huiwei Sun; Rong Li
Journal:  Tumour Biol       Date:  2015-01-28

2.  Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models.

Authors:  Anning Li; Yue Wu; Jenny Linnoila; Benjamin Pulli; Cuihua Wang; Matthias Zeller; Muhammad Ali; Grant K Lewandrowski; Jinghui Li; Benoit Tricot; Edmund Keliher; Gregory R Wojtkiewicz; Giulia Fulci; Xiaoyuan Feng; Bakhos A Tannous; Zhenwei Yao; John W Chen
Journal:  Cancer Immunol Immunother       Date:  2016-10-08       Impact factor: 6.968

3.  Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling.

Authors:  Fatma M Youniss; Gobalakrishnan Sundaresan; Laura J Graham; Li Wang; Collin R Berry; Gajanan K Dewkar; Purnima Jose; Harry D Bear; Jamal Zweit
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

4.  Low dose irradiation increases adoptive cytotoxic T lymphocyte migration in gastric cancer.

Authors:  Juan Du; Shu Su; Hongyan Li; Jie Shao; Fanyan Meng; Mi Yang; Hanqing Qian; Zhengyun Zou; Xiaoping Qian; Baorui Liu
Journal:  Exp Ther Med       Date:  2017-10-13       Impact factor: 2.447

5.  Detection of intramyocardially injected DiR-labeled mesenchymal stem cells by optical and optoacoustic tomography.

Authors:  Markus T Berninger; Pouyan Mohajerani; Moritz Wildgruber; Nicolas Beziere; Melanie A Kimm; Xiaopeng Ma; Bernhard Haller; Megan J Fleming; Stephan Vogt; Martina Anton; Andreas B Imhoff; Vasilis Ntziachristos; Reinhard Meier; Tobias D Henning
Journal:  Photoacoustics       Date:  2017-05-04

6.  Off-Target and Tumor-Specific Accumulation of Monocytes, Macrophages and Myeloid-Derived Suppressor Cells after Systemic Injection.

Authors:  Francis Combes; Séan Mc Cafferty; Evelyne Meyer; Niek N Sanders
Journal:  Neoplasia       Date:  2018-07-18       Impact factor: 5.715

7.  Accumulation and suppressive function of regulatory T cells in malignant ascites: Reducing their suppressive function using arsenic trioxide in vitro.

Authors:  Zilong Hu; Shidong Hu; Youjun Wu; Songyan Li; Changzheng He; Xiaowei Xing; Yufeng Wang; Xiaohui Du
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

8.  Characterization and functional analysis of a slow-cycling subpopulation in colorectal cancer enriched by cell cycle inducer combined chemotherapy.

Authors:  Feng-Hua Wu; Lei Mu; Xiao-Lan Li; Yi-Bing Hu; Hui Liu; Lin-Tao Han; Jian-Ping Gong
Journal:  Oncotarget       Date:  2017-07-26

9.  Tricarbocyanine N-triazoles: the scaffold-of-choice for long-term near-infrared imaging of immune cells in vivo.

Authors:  Richard J Mellanby; Jamie I Scott; Iris Mair; Antonio Fernandez; Louise Saul; Jochen Arlt; Monica Moral; Marc Vendrell
Journal:  Chem Sci       Date:  2018-08-08       Impact factor: 9.825

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.